Claim Discipline: How Brands Avoid Regulatory Risk With Performance Ingredients
Claim Discipline: How Brands Avoid Regulatory Risk With Performance Ingredients
8
CEO & Founder bei Labtree GmbH
A strong active is only an asset if the claim around it can be substantiated. For clinically connoted ingredients, the gap between what a formulation supports and what the label says is where regulatory and reputational risk lives. Claim discipline closes that gap.
Themen auf dieser Seite
Das Thema kurz und kompakt
For clinically connoted actives, the claim has to be tied to documented formulation performance, not to ingredient reputation.
EU Regulation 1223/2009 requires claims to be substantiated and prohibits implying a medical effect; over-claiming is a regulatory and reputational risk.
Developing the formulation and its evidence together makes claim discipline a structural part of the product rather than a final check.
As clinically connoted actives move into mainstream skincare, the temptation to claim a treatment-level effect grows. The same ingredients that make a product attractive also make it easy to imply more than the formulation supports. That gap is the source of regulatory and reputational risk.
The pattern is visible across the regenerative category. As an ingredient such as PDRN spreads, described in our note on PDRN moving into the mainstream, the claim becomes the differentiator, and the pressure to over-claim rises. The same dynamic appears in clinical beauty and bridge-to-clinic positioning, where a product sits close to a treatment and invites a treatment-level expectation. In both, claim discipline is what separates a credible differentiator from a liability.
Why claim discipline matters more now
As clinically connoted actives move into mainstream skincare, the temptation to claim a treatment-level effect grows. The same ingredients that make a product attractive also make it easy to imply more than the formulation supports. That gap is the source of regulatory and reputational risk.
The pattern is visible across the regenerative category. As an ingredient such as PDRN spreads, described in our note on PDRN moving into the mainstream, the claim becomes the differentiator, and the pressure to over-claim rises. The same dynamic appears in clinical beauty and bridge-to-clinic positioning, where a product sits close to a treatment and invites a treatment-level expectation. In both, claim discipline is what separates a credible differentiator from a liability.
What the regulatory framework actually requires
Claim discipline is not only good practice, it reflects what the regulatory framework requires. The figures and rules here are reported as the framework in force, not as legal advice.
Substantiation: cosmetic claims must be supported by adequate evidence appropriate to the claim. A claim that the formulation cannot support is not defensible.
No medical claims: a cosmetic product must not be presented as having a medical or therapeutic effect. Clinically connoted ingredients do not change this boundary.
Fair and honest framing: claims must not mislead, including by implication or omission.
These principles are set out in the EU framework for cosmetic products. Brands selling in the EU should refer to EU Regulation 1223/2009 on cosmetic products and the common criteria for claims made under it. The practical effect is consistent: the claim has to be tied to what the formulation supports.
Defensible claims versus over-claims
The line that matters is between a claim the formulation supports and one it does not. The two can look similar on a label and behave very differently under scrutiny.
Dimension | Defensible claim | Over-claim |
|---|---|---|
Basis | Documented formulation performance | Ingredient reputation alone |
Scope | Cosmetic, formulation-dependent | Implies a medical or treatment-level effect |
Data | Attributed to its source | Unattributed or generalised |
Risk | Manageable | Regulatory and reputational exposure |
The discipline is to describe what the formulation supports, attribute any data to its source, and frame effect as formulation-dependent on form, concentration, delivery and stability. This is not a constraint on marketing so much as a protection for the brand. A measured claim that holds up is worth more than a strong claim that does not.
Building claim discipline into positioning
Claim discipline is most effective when it shapes positioning from the start, rather than being applied as a final check. Three principles tend to hold up:
Claim the mechanism, not the miracle: describe what the formulation is designed to do and why, rather than implying a result it cannot support.
Attribute market data: where a claim rests on market or study data, attribute it to its source and frame it as a reported signal rather than a guarantee.
Match the claim to the validation: the strength of a claim should track the strength of the evidence behind it. A stronger claim needs stronger substantiation.
Positioned this way, claim discipline supports a brand's credibility rather than limiting it, particularly with an informed audience that recognises over-claiming.
How Labtree supports claim discipline
Claim discipline is, at root, a development question. A claim can only be tied to a formulation if the formulation is known, documented and developed for the intended effect. Bolting a claim onto an unknown formulation is where the risk begins.
At Labtree, development happens in our own lab, so the active, concentration and delivery system are chosen deliberately and documented. That lets a brand tie its claim to documented formulation performance rather than to ingredient reputation. Over 1,000 own formulations give a concrete starting point, so a performance concept does not begin in the unknown. Physical samples of pre-qualified formulations ship within 24 hours from the sample warehouse, free of charge for standard samples, so the formulation can be assessed on a real product before any claim is finalised.
Because development and regulatory preparation are handled in one structured workflow, the claim and the documentation behind it develop together. Digital tools support this documentation and alignment, while the development logic, what the formulation actually supports, remains the central factor.
The 5-phase process applied to a claim-disciplined product
Conception: defining the intended claim and the evidence it will need, selecting the active and delivery system to support it, and matching it to a suitable formulation base from the Labtree pool.
Sampling: standard samples of pre-qualified formulations within 24 hours, so the formulation can be assessed on a real product before the claim is fixed.
Individualisation: adjusting concentration, supporting actives and delivery so the formulation supports the intended claim, iterating with further samples where needed.
Prototyping: a production-near test batch, with packaging, design, regulatory requirements and production capability considered early and in parallel rather than only after final formulation approval, so claim substantiation develops with the product.
Production: scaling to the initial batch and into routine production, with claim documentation carried through, coordinated because production capability was considered during prototyping.
Own laboratory: can the formulation be developed and documented for the intended claim, rather than the claim being added to an unknown formula?
Own formulation base: are there pre-qualified bases to start from, so a performance concept does not begin in the unknown?
Regulatory support: can the partner keep claims within EU cosmetic regulation and support substantiation appropriate to the claim?
Claim alignment: a partner who keeps claims close to formulation performance rather than encouraging language the formula cannot support.
Documentation: the formulation, the active source and the evidence documented together, so the claim is traceable.
As performance ingredients become more clinically connoted, claim discipline is no longer a compliance afterthought. It is what separates a credible differentiator from a regulatory and reputational risk. The brands that benefit are those that tie every claim to documented formulation performance, attribute their data and stay within regulatory boundaries. Development in an own lab, with the formulation and its evidence documented together, makes claim discipline a structural part of the product rather than a final hurdle.
Weitere nützliche Links
FAQ
Does Labtree have its own laboratory?
Yes. Labtree has its own development competence including a laboratory. This means formulations are not only selected but specifically developed, tested and adapted. In addition, smaller test batches can be produced in-house to validate products early under real conditions and move them safely into production.
What is claim discipline in cosmetics?
Claim discipline is the practice of tying every product claim to what the formulation can actually support, attributing any data to its source and staying within regulatory boundaries. For clinically connoted actives, it is what separates a credible differentiator from a regulatory and reputational risk.
What does EU cosmetic regulation require for claims?
Under EU Regulation 1223/2009 and the common criteria for cosmetic claims, claims must be substantiated by adequate evidence, must not imply a medical or therapeutic effect, and must not mislead. Brands selling in the EU should refer to the regulation and the criteria directly. This is general information, not legal advice.
Why is over-claiming risky for a clinically connoted ingredient?
A clinically connoted ingredient invites language implying a treatment-level or medical effect that a cosmetic formulation cannot support. That gap creates regulatory exposure and reputational risk when the product does not meet the implied expectation. Keeping claims measured and formulation-dependent reduces that risk.
How can a claim be made defensible?
By tying it to documented formulation performance, attributing any market or study data to its source, and matching the strength of the claim to the strength of the evidence. Effect should be framed as formulation-dependent on form, concentration, delivery and stability rather than on ingredient reputation alone.
Can Labtree help align claims with the formulation?
Yes. Because development happens in our own lab, the active, concentration and delivery system are chosen and documented, and development and regulatory preparation are handled in one workflow. This lets a brand tie its claim to documented formulation performance and keep it within regulatory boundaries.
Jetzt weitere Artikel entdecken
